Cellebrite DI (CLBT) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $316.9 million.

  • Cellebrite DI's Total Current Liabilities rose 16.12% to $316.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $316.9 million, marking a year-over-year increase of 16.12%. This contributed to the annual value of $295.5 million for FY2024, which is 16.42% up from last year.
  • As of Q3 2025, Cellebrite DI's Total Current Liabilities stood at $316.9 million, which was up 2.24% from $310.0 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Total Current Liabilities ranged from a high of $403.7 million in Q3 2021 and a low of $122,983 during Q2 2021.
  • For the 3-year period, Cellebrite DI's Total Current Liabilities averaged around $240.1 million, with its median value being $253.8 million (2023).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first spiked by 140,466.58% in 2022, then slumped by 99.89% in 2023.
  • Over the past 5 years, Cellebrite DI's Total Current Liabilities (Quarterly) stood at $186.6 million in 2021, then increased by 11.36% to $207.8 million in 2022, then rose by 22.16% to $253.8 million in 2023, then climbed by 16.42% to $295.5 million in 2024, then grew by 16.12% to $316.9 million in 2025.
  • Its Total Current Liabilities stands at $316.9 million for Q3 2025, versus $310.0 million for Q2 2025 and $287.8 million for Q1 2025.